Nelson Hamerschlak
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Clinical Trial Using CAR- T Cells for Treatment of Patients With Refractory or Relapsed CD19-positive B Lymphoid Malignancies (NCT05705570) | Nelson Hamerschlak | 2023-02-07 |
Track Nelson Hamerschlak automatically
Every clearance here is in the API, with alerts when new ones post.